Insider · CIK 0001669080

Weiner David B.

Reports to the SEC for 1 company · PLYMOUTH MEETING, PA

sec.gov

Transactions

Companies

Filings

CIK

0001669080

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-20	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionsA Award	Director	AAward	+41.8K sh	—	—	41,800
2026-05-20	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Director	AAward	+34.2K sh	—	—	34,200
2026-02-26	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+972 sh	—	—	87,592
2026-02-26	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−972 sh	—	—	0
2025-05-21	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,167 sh	—	—	86,620
2025-05-21	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−2,167 sh	—	—	0
2025-02-26	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+972 sh	—	—	83,481
2025-02-26	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+972 sh	—	—	84,453
2025-02-26	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−972 sh	—	—	0
2025-02-26	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−972 sh	—	—	972
2024-05-21	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionsA Award	Director	AAward	+2,917 sh	—	—	2,917
2024-05-21	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Director	AAward	+2,167 sh	—	—	2,167
2024-05-15	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,166 sh	—	—	82,509
2024-05-15	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−2,166 sh	—	—	0
2024-02-26	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+972 sh	—	—	78,399
2024-02-26	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+972 sh	—	—	79,371
2024-02-26	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+972 sh	—	—	80,343
2024-02-26	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−972 sh	—	—	0
2024-02-26	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−972 sh	—	—	972
2024-02-26	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−972 sh	—	—	1,944
2023-05-16	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+19K sh	—	—	929,124
2023-05-16	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−19K sh	—	—	0
2023-05-15	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionsA Award	Director	AAward	+35K sh	—	—	35,000
2023-05-15	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Director	AAward	+26K sh	—	—	26,000
2023-03-13	INOINOVIO PHARMACEUTICALS, INC.S Sale	Director	SSale	−5,833 sh	$1.15	−$6,707.95	910,124
2023-03-11	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+11.7K sh	—	—	915,957
2023-03-11	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−11.7K sh	—	—	0
2023-02-27	INOINOVIO PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.7K sh	$1.28	−$14.9K	904,291
2023-02-27	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionA Award	Director	AAward	+60K sh	—	—	60,000
2023-02-27	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Director	AAward	+35K sh	—	—	35,000
2023-02-26	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+11.7K sh	—	—	904,292
2023-02-26	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+11.7K sh	—	—	915,959
2023-02-26	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−11.7K sh	—	—	11,666
2023-02-26	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−11.7K sh	—	—	23,333
2022-08-11	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+11.9K sh	$2.16	+$25.7K	904,500
2022-08-11	INOINOVIO PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.9K sh	$2.66	−$31.6K	892,625
2022-08-11	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−11.9K sh	—	—	11,875
2022-05-16	INOINOVIO PHARMACEUTICALS, INC.S Sale	Director	SSale	−9,000 sh	$1.95	−$17.6K	892,625
2022-05-16	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Director	AAward	+19K sh	—	—	19,000
2022-05-16	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionsA Award	Director	AAward	+28K sh	—	—	28,000
2022-05-13	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+18K sh	—	—	901,625
2022-05-13	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−18K sh	—	—	0
2022-03-14	INOINOVIO PHARMACEUTICALS, INC.S Sale	Director	SSale	−4,083 sh	$3.20	−$13.1K	883,625
2022-03-11	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+11.7K sh	—	—	887,708
2022-03-11	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−11.7K sh	—	—	11,666
2022-03-09	INOINOVIO PHARMACEUTICALS, INC.S Sale	Director	SSale	−4,083 sh	$3.33	−$13.6K	876,041
2022-03-08	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+11.7K sh	—	—	880,124
2022-03-08	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−11.7K sh	—	—	0
2022-02-26	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+11.7K sh	—	—	868,458
2022-02-26	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−11.7K sh	—	—	23,333

Recent filings

Accepted (ET)
May 214
Weiner David B.0001669080-26-000003
SEC(opens sec.gov)
Feb 274
Weiner David B.0001669080-26-000002
SEC(opens sec.gov)
May 214
Weiner David B.0001055726-25-000032
SEC(opens sec.gov)
Feb 284
Weiner David B.0001055726-25-000001
SEC(opens sec.gov)
May 224
Weiner David B.0001055726-24-000038
SEC(opens sec.gov)
May 164
Weiner David B.0001055726-24-000028
SEC(opens sec.gov)
Feb 284
Weiner David B.0001055726-24-000006
SEC(opens sec.gov)

Companies

INOVIO PHARMACEUTICALS, INC.DirectorINO

Address

660 W. GERMANTOWN PIKE SUITE 110

PLYMOUTH MEETING, PA, 19462